In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics.
Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system.
Monitoring glucose values is necessary for diabetes patients, and technologically advanced systems make it much easier for patients to self-manage the disease, according to Kaufman.
Kaufman has been a practicing pediatric endocrinologist with a focus on diabetes for almost 45 years. She joined the team at Senseonics in 2019. She states that with the company’s CGM system, the team created an innovative and somewhat disruptive way to continuously monitor glucose, that provides a highly accurate choice for people to consider versus the traditional transcutaneous systems.
She illustrates how the information collected from the CGM can ultimately help physicians and patients better understand their disease and turn that data into actionable insights.
In the video below, Kaufman also describes how diabetes healthcare has changed over the years, how AI may transform diabetes monitoring and care, and how Senseonics hopes to advance its sensors in the coming years to make managing the disease even easier for patients.
The post Health Innovators: Senseonics’ Francine Kaufman appeared first on .
